Jesse Anderson Corley is Director at RxSight, Inc. (RXST). They have made 4 open-market trades across 1 company since 2021, most recently 2026-06-17.
CIK 0001874878
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $3.4M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RXST | 86,227 | $389K |
Shares reported on the most recent Form 4, priced at the 2026-06-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXST | BUY | 2025-01-15 | 2025-01-17 | $31.15 | $155K | +4.7% | -1.8% | -54.0% |
| RXST | BUY | 2024-11-12 | 2024-11-14 | $45.16 | $1.8M | +2.5% | -14.3% | -29.0% |
| RXST | SELL · 10b5-1 | 2024-01-08 | 2024-01-09 | $45.03 | $90K | +2.9% | +6.3% | +22.3% |
| RXST | SELL · 10b5-1 | 2023-12-14 | 2023-12-18 | $40.12 | $481K | +2.4% | +15.7% | +18.8% |
| RXST | BUY | 2021-11-17 | 2021-11-18 | $12.49 | $204K | -14.8% | -27.1% | +5.3% |
| RXST | BUY | 2021-08-03 | 2021-08-05 | $16.00 | $1.3M | -14.4% | +14.4% | -6.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.